Brainomix’s AI-enabled stroke software endorsed by NICE
The HTA reported that Brainomix 360 improved access to treatment for stroke patients
Read More
Tag: Brainomix
Brainomix’s e-Lung enters TIPAL trial
The company will use its AI technology during a sub-study to analyse the effect of lansoprazole
Read More
UK atrial fibrillation research incorporates Brainomix
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
Read More
Brainomix and Visionable announce AI partnership
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK
Read More
Brainomix in collaboration with UK Government-funded NCIMI
Partnership will evaluate AI-powered technology in lung cancer care
Read More
Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership
Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
